# Bioequivalence Study of Ziprasidone HCL Capsules, 20 mg Under Fasting Conditions

> **NCT01581866** · PHASE1 · COMPLETED · sponsor: **Dr. Reddy's Laboratories Limited** · enrollment: 56 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Ziprasidone Hydrochloride

## Key facts

- **NCT ID:** NCT01581866
- **Lead sponsor:** Dr. Reddy's Laboratories Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-11
- **Primary completion:** 2004-11
- **Final completion:** 2005-01
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2012-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01581866

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01581866, "Bioequivalence Study of Ziprasidone HCL Capsules, 20 mg Under Fasting Conditions". Retrieved via AI Analytics 2026-07-11 from https://api.ai-analytics.org/clinical/NCT01581866. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*